U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H9O4.Na
Molecular Weight 216.1658
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SODIUM FERULATE

SMILES

[Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O

InChI

InChIKey=NCTHNHPAQAVBEB-WGCWOXMQSA-M
InChI=1S/C10H10O4.Na/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13;/h2-6,11H,1H3,(H,12,13);/q;+1/p-1/b5-3+;

HIDE SMILES / InChI
Molecular Formula C10H9O4
Molecular Weight 193.1761
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE
Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

2009
364
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8504
 9.78 µM [Ki]
Inhibitor
8504
 9.87 µM [Ki]
Inhibitor
8504
 7.41 µM [Ki]
Inhibitor
8504
 9.43 µM [Ki]
Inhibitor
8504
 7.04 µM [Ki]
Inhibitor
8504
 2.89 µM [Ki]
Inhibitor
8504
 2.4 µM [Ki]
Inhibitor
8504
 3.78 µM [IC50]
PubMed

PubMed

TitleDatePubMed
Anticonvulsant and behavioral effects observed in mice following treatment with an ester derivative of ferulic acid: Isopentyl ferulate.
2015-12-05
Investigation of the effects of some drugs and phenolic compounds on human dihydrofolate reductase activity.
2015-03
Investigation of the effects of some phenolic compounds on the activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from human erythrocytes.
2014-11
Antifungal efficacy of some natural phenolic compounds against significant pathogenic and toxinogenic filamentous fungi.
2013-10
Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus.
2013
Anti-inflammatory activity of hydroxycinnamic acid derivatives isolated from corn bran in lipopolysaccharide-stimulated Raw 264.7 macrophages.
2012-05
Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adipocytes.
2011-09-28
Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.
2011-07-29
Ferulic acid protects against carbon tetrachloride-induced liver injury in mice.
2011-04-11
Restoration of altered microRNA expression in the ischemic heart with resveratrol.
2010-12-23
Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium.
2010-12-05
Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines.
2010-10-06
Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: comparison with clofibrate.
2010-03-12
Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.
2008-12-15
Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin.
2008-08-08
Influence of ferulic acid on nicotine-induced lipid peroxidation, DNA damage and inflammation in experimental rats as compared to N-acetylcysteine.
2008-01-20
Analysis of interaction property of bioactive components in Danggui Buxue Decoction with protein by microdialysis coupled with HPLC-DAD-MS.
2007-06-01
Predicting the biological activities of 2-methoxyphenol antioxidants: effects of dimers.
2007-04-18
Synergistic salubrious effect of ferulic acid and ascorbic acid on membrane-bound phosphatases and lysosomal hydrolases during experimental myocardial infarction in rats.
2006-12-23
Modulation of hepatic phase II phenol sulfotransferase and antioxidant status by phenolic acids in rats.
2006-08
Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid.
2006-05
Synergistic interactions of ferulic acid with ascorbic acid: its cardioprotective role during isoproterenol induced myocardial infarction in rats.
2006-02
Ferulic acid, a natural protector against carbon tetrachloride-induced toxicity.
2005-08
Antioxidant and antigenotoxic effects of plant cell wall hydroxycinnamic acids in cultured HT-29 cells.
2005-06
Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans.
2005-02
Ferulic acid inhibits endothelial cell proliferation through NO down-regulating ERK1/2 pathway.
2004-12-15
Free radical scavengers and antioxidants from Baccharis grisebachii.
2004-12
Interactions of human serum albumin with chlorogenic acid and ferulic acid.
2004-09-24
Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II.
2004-09-19
Influence of ferulic acid on circulatory prooxidant-antioxidant status during alcohol and PUFA induced toxicity.
2004-09
Rye bran bread intake elevates urinary excretion of ferulic acid in humans, but does not affect the susceptibility of LDL to oxidation ex vivo.
2004-08
Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation.
2004-07-02
Antitubercular constituents of Valeriana laxiflora.
2004-06
Antioxidant effect of ferulic acid in isolated membranes and intact cells: synergistic interactions with alpha-tocopherol, beta-carotene, and ascorbic acid.
2004-04-21
Reference values for urinary steroids in Japanese newborn infants: gas chromatography/mass spectrometry in selected ion monitoring.
2003-12
Antiviral activity of Plantago major extracts and related compounds in vitro.
2002-07
In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents.
2000-04-10
Bioactive constituents of the bark of Parkia biglobosa.
2000-04
Metabolites of orally administered Perilla frutescens extract in rats and humans.
2000-01
Investigation of the potential of capillary electrophoresis with off-line matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for clinical analysis: examination of a glycoprotein factor associated with cancer cachexia.
1999-02-15
Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat.
1998-04-30
Isolation and quantitation of steroids from normal human amniotic fluid.
1968-08
Patents

Patents

JP1013016A
2
JP2000041622A
2
JP2000125840A
2
JP2000129257A
2
JP2000229913A
2
JP2000247900A
4
JP2000273019A
3
JP2000308477A
4
JP2000325015A
2
JP2000325049A
2
JP2001161314A
2
JP2001253863A
2
JP2001354556A
2
JP2002003386A
2
JP2002030039A
2
JP2002053464A
4
JP2002080354A
4
JP2002080355A
4
JP2002080356A
4
JP2002080357A
4
JP2002080381A
4
JP2002145765A
4
JP2002145766A
2
JP2002145767A
2
JP2002154977A
4
JP2002180081A
8
JP2002255778A
10
JP2002291406A
4
JP2002291437A
2
JP2002363075A
2
JP2002371002A
2
JP2002533379A
53
JP2002541233A
406
JP2003033196A
7
JP2003038144A
2
JP2003040709A
2
JP2003055182A
2
JP2003081824A
4
JP2003128632A
2
JP2003128633A
2
JP2003212774A
2
JP2003261444A
4
JP2003292410A
2
JP2003515526A
470
JP2003516112A
4
JP2003531246A
4
JP2003531247A
7
JP2004026657A
2
JP2004049186A
2
JP2004065156A
2
JP2004137287A
4
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:06:56 GMT 2025
Edited
by admin
on Mon Mar 31 18:06:56 GMT 2025
Record UNII
OIS7F1IRQK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM FERULATE
INCI   WHO-DD  
INCI  
Official Name English
SODIUM 3-METHOXY-4-HYDROXYCINNAMATE
FHFI  
Preferred Name English
CINNAMIC ACID, 4-HYDROXY-3-METHOXY-, MONOSODIUM SALT
Common Name English
FEMA NO. 3812
Code English
Sodium ferulate [WHO-DD]
Common Name English
SODIUM 3-METHOXY-4-HYDROXYCINNAMATE [FHFI]
Common Name English
Code System Code Type Description
WIKIPEDIA
SODIUM FERULATE
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
EPA CompTox
DTXSID80894080
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
EVMPD
SUB32882
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
FDA UNII
OIS7F1IRQK
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
CAS
24276-84-4
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
PUBCHEM
23669636
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
SMS_ID
100000125893
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
NCI_THESAURUS
C84155
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
MESH
C004999
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
CONCEPT Industrial Aid
JECFA MONOGRAPH
1992
Created by admin on Mon Mar 31 18:06:56 GMT 2025 , Edited by admin on Mon Mar 31 18:06:56 GMT 2025
PRIMARY
Related Record Type Details
Structure of FERULIC ACID
PARENT -> SALT/SOLVATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966